On 2026-05-11, Bicara Therapeutics Inc. (BCAX) announced earnings per share of $-0.93 for the fiscal quarter ending 2026-03-31, missing the average analyst estimate of $-0.64.
The next expected annoucement date for quarterly earnings is 2026-08-11, with an average estimated earnings per share of $-0.78 for the fiscal quarter ending 2026-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-05-11 | 2026-03-31 | $-0.64 | $-0.93 |
| 2026-03-30 | 2025-12-31 | $-0.72 | $-0.68 |
| 2025-11-10 | 2025-09-30 | $-0.55 | $-0.67 |
| 2025-08-12 | 2025-06-30 | $-0.54 | $-0.50 |
| 2025-05-13 | 2025-03-31 | $-0.40 | $-0.68 |
| 2025-03-27 | 2024-12-31 | $-0.31 | $-0.39 |
| 2024-11-12 | 2024-09-30 | $-0.46 | $-1.60 |